Lin Chang, MD
UCLA
David Geffen School of Medicine
Los Angeles, CA

Professor of Medicine
Department of Medicine
Division of Digestive Diseases
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, California

Lin Chang, MD, is a Professor of Medicine in the Department of Medicine, Division of Digestive Diseases, at the David Geffen School of Medicine at UCLA. She serves as the Co-Director of the Center for Neurobiology of Stress at the David Geffen School of Medicine at UCLA. This center is an interdisciplinary research and education organization, dedicated to the study of brain-body interactions in health and disease. Dr. Chang earned her medical degree from the UCLA School of Medicine and completed her internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed her gastroenterology fellowship training at the UCLA Affiliated Training Program in Gastroenterology. Dr. Chang’s clinical expertise is in functional gastrointestinal disorders which include irritable bowel syndrome (IBS), chronic constipation, and functional dyspepsia. Dr. Chang’s research is focused on the pathophysiology of IBS related to stress, sex differences, and neuroendocrine alterations and the treatment of IBS. She is a funded NIH-investigator studying the central and peripheral mechanisms underlying IBS. She is the recipient of the Janssen Award in Gastroenterology for Basic or Clinical Research and the AGA Distinguished Clinician Award, Dr. Chang has authored more than 70 original research articles, 48 review articles, and 19 book chapters on her specialty interests and is a frequent speaker at national and international meetings. She is a fellow of the American Gastroenterological Association and an active member of several professional societies, including the American College of Gastroenterology and the Society for Neuroscience. She is also a member of the Rome Foundation Board of Directors and served as the Co-Chair of the Rome III Gender, Age, Cultural and Patient Perspective committee. She is the President Elect in the newly merged American Neurogastroenterology and Motility Society (ANMS). She served on the FDA GI Advisory Committee from 2005-2010 which she also chaired.

UCLA - David Geffen School of Medicine

In just over 50 years - within the lifetimes of many of its original architects - the David Geffen School of Medicine at UCLA has joined the ranks of the nations elite medical schools.

The medical school today has more than 2,000 full-time faculty members, almost 1,300 residents, more than 750 medical students and almost 400 Ph.D. candidates. The UCLA Medical Center has been ranked "Best in the West" by U.S. News and World Report's annual survey of the best hospitals in America for fourteen consecutive years. The medical school is ranked ninth in the country in research funding from the National Institutes of Health and third in the United States in research dollars from all sources.

The Ronald Reagan UCLA Medical Center, designed by I.M. Pei, opened its doors in 2008 and is a model for state-of-the-art medical science and patient care in a patient- and staff-friendly environment. The new Santa Monica-UCLA Medical Center replacement hospital, designed by prominent New York architect Robert A.M. Stern in conjunction with CO Architects, opened its doors in 2008.

In 2010, Dr. A. Eugene Washington, an internationally renowned clinical investigator and health policy scholar whose wide-ranging research has been instrumental in shaping national health policy and practice guidelines, joined UCLA Feb. 1 as Vice Chancellor of UCLA Health Sciences and Dean of the David Geffen School of Medicine.

The dream of the school's founders has been realized. The David Geffen School of Medicine is an internationally recognized leader in research, medical education, and patient care.

Content available soon!

 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (IRIS-4)

Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointestinal disorder characterised by chronic or recurrent abdominal pain or discomfort and diarrhoea. This trial aims at the evaluation of the efficacy and safety of oral ibodutant 10 mg once daily as compared to placebo in women with IBS-D over a 24-week treatment period

Estimated Enrollment: 500
Study Start Date: March 2014
Estimated Study Completion Date: April 2016
Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)

Ages Eligible for Study: 18 Years and older
Genders Eligible for Study: Female
Accepts Healthy Volunteers: No

    Webcasts

    An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice

    Brian E. Lacy, MD (chair), Darren M. Brenner, MD, Brooks D. Cash, MD, Philip S. Schoenfeld, MD

    Didactic Lecture

    view details >

    Beyond Gut Instincts: Applying the latest IBS advances to practice

    William D. Chey, MD, Stanley A Cohen, MD, Nicholas Talley, MD, Mark Pimentel, MD, Philip S. Schoenfeld, MD

    Didactic Lecture

    view details >

    Functional dyspepsia: A new disease model

    Nick Talley, MD

    Didactic Lecture

    view details >

    Integrating Novel Diagnostic Strategies into Practice: Key Points

    Stanley Cohen, MD

    Didactic Lecture

    view details >

    Novel Strategies for IBS-C

    Mark Pimentel, MD

    Didactic Lecture

    view details >

    Diagnosis and Treatment of SIBO

    Satish Rao, MD

    Didactic Lecture

    view details >

    Insights into Lactose Intolerance

    Yuri Saito, MD

    Didactic Lecture

    view details >

    Chronic Nausea and Vomiting: It's not always gastroparesis

    Lawrence Schiller, MD

    Didactic Lecture

    view details >

    Management of Severe Constipation: Dysnnergic Defecation and OIC

    Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Rifaximin for IBS-D

    Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Diagnostic Testing in Irritable Bowel Syndrome

    Brennan Spiegel, MD

    Didactic Lecture

    view details >

    Which Diet is Right for IBS?

    William Chey, MD

    Didactic Lecture

    view details >

    Emerging Medical Management Options for IBS-D

    William Chey, MD

    Didactic Lecture

    view details >

    Opioid Induced Constipation

    Brooks Cash, MD

    Didactic Lecture

    view details >

    Overview of IBS-C Therapies

    Christine Frissora, MD

    Didactic Lecture

    view details >

    A Primer on the Diagnosis and Management of Functional Dyspepsia

    Brian Lacy, MD

    Didactic Lecture

    view details >

    Distinguishing Celiac Disease, Non-Gluten Sensitivity and IBS

    Lucinda Harris, MD

    Didactic Lecture

    view details >

    New IBS Biomarker

    Mark Pimentel, MD

    Didactic Lecture

    view details >

    Understanding and Managing Gastroparesis

    Linda Nguyen, MD

    Didactic Lecture

    view details >

    Opioid-Induced Bowel Dysfunction

    Darren Brenner, MD

    Didactic Lecture

    view details >

    Xpert Perspectives: New Insights into the Recognition and Management of FGIMDs 2015

    Brooks Cash, MD, William Chey, MD, Mark Pimentel, MD

    Didactic Lecture

    view details >

    Xpert Perspectives: Reporting on FGIMDs

    Lin Chang, MD, William Chey, MD, Mark Pimentel, MD,

    Didactic Lecture

    view details >

    Gi News Tonight: Case Discussions on Functional GI and Motility Disorders

    Lawrence Schiller, MD, Lin Chang, MD, Mark Pimentel, MD, Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    eMonograph

    An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice

    view details >

    Advances in IBS

    view details >

    IBS News Tonight

    view details >

    Advances in the Management of FGIDs

    view details >

    Gastroparesis: Diagnosis and Management

    view details >

    Managing the Gastrointestinal Effects of Opioids

    view details >

    Painful Diverticular Disease or Irritable Bowel Syndrome?

    view details >

    Advances in IBS 2012

    view details >

    Implementing Effective Patient Communication Skills in IBS

    view details >

    Dietary Interventions in IBS: An Update

    view details >

    New and Emerging Pharmacologic Therapies for Irritable Bowel Syndrome with Diarrhea

    view details >

    Advances in the Management of Irritable Bowel Syndrome: A Report from Digestive Disease Week 2011

    view details >

    The Gut Microbiome and Irritable Bowel Syndrome: Is There a Link?

    view details >

    Webcasts

    An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice

    Brian E. Lacy, MD (chair), Darren M. Brenner, MD, Brooks D. Cash, MD, Philip S. Schoenfeld, MD

    Didactic Lecture

    view details >

    Beyond Gut Instincts: Applying the latest IBS advances to practice

    William D. Chey, MD, Stanley A Cohen, MD, Nicholas Talley, MD, Mark Pimentel, MD, Philip S. Schoenfeld, MD

    Didactic Lecture

    view details >

    Functional dyspepsia: A new disease model

    Nick Talley, MD

    Didactic Lecture

    view details >

    Integrating Novel Diagnostic Strategies into Practice: Key Points

    Stanley Cohen, MD

    Didactic Lecture

    view details >

    Novel Strategies for IBS-C

    Mark Pimentel, MD

    Didactic Lecture

    view details >

    Diagnosis and Treatment of SIBO

    Satish Rao, MD

    Didactic Lecture

    view details >

    Insights into Lactose Intolerance

    Yuri Saito, MD

    Didactic Lecture

    view details >

    Chronic Nausea and Vomiting: It's not always gastroparesis

    Lawrence Schiller, MD

    Didactic Lecture

    view details >

    Management of Severe Constipation: Dysnnergic Defecation and OIC

    Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Rifaximin for IBS-D

    Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Diagnostic Testing in Irritable Bowel Syndrome

    Brennan Spiegel, MD

    Didactic Lecture

    view details >

    Which Diet is Right for IBS?

    William Chey, MD

    Didactic Lecture

    view details >

    Emerging Medical Management Options for IBS-D

    William Chey, MD

    Didactic Lecture

    view details >

    Opioid Induced Constipation

    Brooks Cash, MD

    Didactic Lecture

    view details >

    Overview of IBS-C Therapies

    Christine Frissora, MD

    Didactic Lecture

    view details >

    A Primer on the Diagnosis and Management of Functional Dyspepsia

    Brian Lacy, MD

    Didactic Lecture

    view details >

    Distinguishing Celiac Disease, Non-Gluten Sensitivity and IBS

    Lucinda Harris, MD

    Didactic Lecture

    view details >

    New IBS Biomarker

    Mark Pimentel, MD

    Didactic Lecture

    view details >

    Understanding and Managing Gastroparesis

    Linda Nguyen, MD

    Didactic Lecture

    view details >

    Opioid-Induced Bowel Dysfunction

    Darren Brenner, MD

    Didactic Lecture

    view details >

    Xpert Perspectives: New Insights into the Recognition and Management of FGIMDs 2015

    Brooks Cash, MD, William Chey, MD, Mark Pimentel, MD

    Didactic Lecture

    view details >

    Xpert Perspectives: Reporting on FGIMDs

    Lin Chang, MD, William Chey, MD, Mark Pimentel, MD,

    Didactic Lecture

    view details >

    Gi News Tonight: Case Discussions on Functional GI and Motility Disorders

    Lawrence Schiller, MD, Lin Chang, MD, Mark Pimentel, MD, Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Dinner Meetings

    Content available soon

    Audiocasts

    Content available soon!

    Content available soon!

    © Copyright 2013-2017 GI Health Foundation. All rights reserved.
    This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.